|
|
 |
|
| | |
| | | | | |
gene
|
|
PR:000007049 |
endomucin
|
EMCN
|
"A protein that is a translation product of the human EMCN gene or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q6AY82 |
endomucin (rat)
|
rEMCN
|
"An endomucin that is encoded in the genome of rat." [OMA:Q6AY82, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q9R0H2 |
endomucin (mouse)
|
mEMCN
|
"An endomucin that is encoded in the genome of mouse." [OMA:Q9R0H2, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q9R0H2-1 |
endomucin isoform m1 (mouse)
|
mEMCN/iso:m1
|
"An endomucin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9R0H2-1." [PRO:DNx, UniProtKB:Q9R0H2]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q9R0H2-2 |
endomucin isoform m2 (mouse)
|
mEMCN/iso:m2
|
"An endomucin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9R0H2-2." [PRO:DNx, UniProtKB:Q9R0H2]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q9R0H2-3 |
endomucin isoform m3 (mouse)
|
mEMCN/iso:m3
|
"An endomucin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9R0H2-3." [PRO:DNx, UniProtKB:Q9R0H2]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q9R0H2-4 |
endomucin isoform m4 (mouse)
|
mEMCN/iso:m4
|
"An endomucin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9R0H2-4." [PRO:DNx, UniProtKB:Q9R0H2]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q9ULC0 |
endomucin (human)
|
hEMCN
|
"An endomucin that is encoded in the genome of human." [PRO:DNx, UniProtKB:Q9ULC0]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q9ULC0-1 |
endomucin isoform h1 (human)
|
hEMCN/iso:h1
|
"An endomucin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ULC0-1." [PRO:DNx, UniProtKB:Q9ULC0]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q9ULC0-2 |
endomucin isoform h2 (human)
|
hEMCN/iso:h2
|
"An endomucin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ULC0-2." [PRO:DNx, UniProtKB:Q9ULC0]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q9ULC0-3 |
endomucin isoform h3 (human)
|
hEMCN/iso:h3
|
"An endomucin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ULC0-3." [PRO:DNx, UniProtKB:Q9ULC0]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058296 |
endomucin O-glycosylated 1 (human)
|
hEMCN/OGlyco:1
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-140 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q9ULC0-1, Ser-140, MOD:00002~GNO:G29068FM." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058297 |
endomucin O-glycosylated 2 (human)
|
hEMCN/OGlyco:2
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-140 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULC0-1, Ser-140, MOD:00002~GNO:G43417UB." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058298 |
endomucin O-glycosylated 3 (human)
|
hEMCN/OGlyco:3
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-166 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q9ULC0-1, Ser-166, MOD:00002~GNO:G29068FM." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058299 |
endomucin O-glycosylated 4 (human)
|
hEMCN/OGlyco:4
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-166 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULC0-1, Ser-166, MOD:00002~GNO:G43417UB." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058300 |
endomucin O-glycosylated 5 (human)
|
hEMCN/OGlyco:5
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-166 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q9ULC0-1, Ser-166, MOD:00002~GNO:G53434XO." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058301 |
endomucin O-glycosylated 6 (human)
|
hEMCN/OGlyco:6
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-168 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q9ULC0-1, Ser-168, MOD:00002~GNO:G29068FM." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058302 |
endomucin O-glycosylated 7 (human)
|
hEMCN/OGlyco:7
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-168 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULC0-1, Ser-168, MOD:00002~GNO:G43417UB." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058303 |
endomucin O-glycosylated 8 (human)
|
hEMCN/OGlyco:8
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Ser-76 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULC0-1, Ser-76, MOD:00002~GNO:G43417UB." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058304 |
endomucin O-glycosylated 9 (human)
|
hEMCN/OGlyco:9
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-118 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q9ULC0-1, Thr-118, MOD:00005~GNO:G29068FM." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058305 |
endomucin O-glycosylated 10 (human)
|
hEMCN/OGlyco:10
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-134 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q9ULC0-1, Thr-134, MOD:00005~GNO:G53434XO." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058306 |
endomucin O-glycosylated 11 (human)
|
hEMCN/OGlyco:11
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-134 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G73004SD. Example: UniProtKB:Q9ULC0-1, Thr-134, MOD:00005~GNO:G73004SD." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058307 |
endomucin O-glycosylated 12 (human)
|
hEMCN/OGlyco:12
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-135 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULC0-1, Thr-135, MOD:00005~GNO:G43417UB." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058308 |
endomucin O-glycosylated 13 (human)
|
hEMCN/OGlyco:13
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-155 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q9ULC0-1, Thr-155, MOD:00005~GNO:G53434XO." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058309 |
endomucin O-glycosylated 14 (human)
|
hEMCN/OGlyco:14
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-165 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q9ULC0-1, Thr-165, MOD:00005~GNO:G53434XO." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058310 |
endomucin O-glycosylated 15 (human)
|
hEMCN/OGlyco:15
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-165 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:Q9ULC0-1, Thr-165, MOD:00005~GNO:G57317CE." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058311 |
endomucin O-glycosylated 16 (human)
|
hEMCN/OGlyco:16
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-165 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q9ULC0-1, Thr-165, MOD:00005~GNO:G58001LT." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058312 |
endomucin O-glycosylated 17 (human)
|
hEMCN/OGlyco:17
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-64 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q9ULC0-1, Thr-64, MOD:00005~GNO:G29068FM." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058313 |
endomucin O-glycosylated 18 (human)
|
hEMCN/OGlyco:18
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-64 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULC0-1, Thr-64, MOD:00005~GNO:G43417UB." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058314 |
endomucin O-glycosylated 19 (human)
|
hEMCN/OGlyco:19
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-64 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q9ULC0-1, Thr-64, MOD:00005~GNO:G58001LT." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058315 |
endomucin O-glycosylated 20 (human)
|
hEMCN/OGlyco:20
|
"An endomucin (human) that has been O-glycosylated at the residue equivalent to Thr-77 of the amino acid sequence represented by UniProtKB:Q9ULC0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULC0-1, Thr-77, MOD:00005~GNO:G43417UB." [GlyGen:Q9ULC0-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
